Scopus, the largest abstract and citation database of peer-reviewed literature, was chosen by the University of Miami because the breadth of the content allows the university to accurately capture the greatest amount of faculty research activity from a single data source. This also makes Miami the first academic institution in the United States to use SCD for this type of measurement and tracking.

"We are using Scopus Custom Data to link the University of Miami's unique faculty identifier with the Scopus author ID to better track faculty scholarly activity regardless of the institutional affiliation at the time of publication, " said Jared Abramson, Director, Research Reporting at the University of Miami. "Insight into the expertise of each of our faculty members allows us to promote collaboration, and to build interdisciplinary teams for institutional research projects."

The use of SCD for this type of measurement is increasingly becoming the standard among different institutions. As research continues to become more interdisciplinary and cross-functional, the need for a singular, more accurate and comprehensive research tool, such as Scopus becomes a necessity for academic institutions to remain competitive.

"We are obviously very pleased by how the University of Miami has leveraged Scopus Custom Data through this collaboration" commented Niels Weertman, Director Scopus, Performance & Planning at Elsevier in the Academic & Government Products Group. "And, we see it as a significant step forward in the advancement of research methods and international collaboration."

About Scopus

Covering the world's research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality Web sources with smart tools to track analyze and visualize research. Scopus was designed and developed with over 500 users and librarians internationally. Its unique database contains abstracts and references from nearly 18,000 titles from more than 5,000 international publishers, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also directly integrates Web and patent searches. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit http://www.info.scopus.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact:
    Marwa Salem
    Phone: +31-20-485-2674
    E-mail: m.salem@elsevier.com

Contact: Marwa Salem, Phone: +31-20-485-2674, E-mail: m.salem@elsevier.com

Scopus, the largest abstract and citation database of peer-reviewed literature, was chosen by the University of Miami because the breadth of the content allows the university to accurately capture the greatest amount of faculty research activity from a single data source. This also makes Miami the first academic institution in the United States to use SCD for this type of measurement and tracking.

"We are using Scopus Custom Data to link the University of Miami's unique faculty identifier with the Scopus author ID to better track faculty scholarly activity regardless of the institutional affiliation at the time of publication, " said Jared Abramson, Director, Research Reporting at the University of Miami. "Insight into the expertise of each of our faculty members allows us to promote collaboration, and to build interdisciplinary teams for institutional research projects."

The use of SCD for this type of measurement is increasingly becoming the standard among different institutions. As research continues to become more interdisciplinary and cross-functional, the need for a singular, more accurate and comprehensive research tool, such as Scopus becomes a necessity for academic institutions to remain competitive.

"We are obviously very pleased by how the University of Miami has leveraged Scopus Custom Data through this collaboration" commented Niels Weertman, Director Scopus, Performance & Planning at Elsevier in the Academic & Government Products Group. "And, we see it as a significant step forward in the advancement of research methods and international collaboration."

About Scopus

Covering the world's research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality Web sources with smart tools to track analyze and visualize research. Scopus was designed and developed with over 500 users and librarians internationally. Its unique database contains abstracts and references from nearly 18,000 titles from more than 5,000 international publishers, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also directly integrates Web and patent searches. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit http://www.info.scopus.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

    Contact:
    Marwa Salem
    Phone: +31-20-485-2674
    E-mail: m.salem@elsevier.com

SOURCE Elsevier

Each live, 65-minute webcast in the Scholarly Perspectives 2009 series will focus on a key issue impacting today's academic libraries and feature both a senior librarian and researcher from the hosting university as well as an Elsevier representative. A brief question and answer session will close each event. Following are details on the three webinars:

- "Research Without Borders: Interdisciplinary Research" - Hosted by the
       University of Aberdeen, November 2nd, 9:00 a.m. - 10:30 a.m. GMT.
       Topics scheduled:

    - "A library menu of tools to aid interdisciplinary research and
       discovery"

    - "Creating inter-content connections and locating knowledgeable experts
       in new fields with a case example on Carbon Capture & Storage"

    - "Researcher case study: How scholarly data retrieval and expert finding
       in new and related fields works in practice with a case example on
       Carbon Capture & Storage."

    - "A Life Science Lens: Connecting to Relevant Sources" - Hosted by
       Princeton University November 20th, 9:00 a.m. - 10:30 a.m. EST.
       Topics scheduled:

    - "Researcher case study: Framing the information retrieval challenge for
       the life scientist"

    - "How can library services and expertise help address the Life
       scientist's information retrieval challenge?"

    - "Using smart technology to accelerate life science research"

    - "Enriching Research and Teaching Through Ebook Content" - Hosted by
       Hong Kong University, November 30th, 9:00 a.m. - 10:30 a.m. GMT.
       Topics scheduled:

    - "Understanding the role of Ebooks in the research workflow"

    - "Hong Kong University: Lessons learned from building the world's
       largest Ebook collection"

    - "Course case study: A primer on building Ebooks into a course reading
       list"

If you are interested in registering for any one of webinars in the Scholarly Perspectives 2009 series or for more information, please contact Jessica Disch at jdisch@psbpr.com or +1-212-752-8338.

About ScienceDirect

Over a quarter of the world's full text scientific, technical and medical (STM) peer-reviewed articles - managed by renowned editors, written by respected authors and read by researchers from around the globe - are available in one place: ScienceDirect.

Elsevier's extensive and unique full-text collection covers authoritative titles from the core scientific literature including high impact factor titles such as THE LANCET, Cell and Tetrahedron. Over nine million articles are available online, including Articles in Press which offer online access to recently accepted manuscripts. The critical mass of trusted information available on ScienceDirect is unsurpassed. Coverage includes over 2,500 journals published by Elsevier and dynamic linking to journals from approximately 2,000 STM publishers through CrossRef. An expanding program of online major reference works, handbooks, book series and over 4,400 eBooks in all fields of science seamlessly interlinks with primary research referenced in journal articles.

About Scopus

Covering the world's research literature, Scopus is the largest abstract and citation database of peer-reviewed literature and quality Web sources with smart tools to track analyze and visualize research. Scopus was designed and developed with over 500 users and librarians internationally. Its unique database contains abstracts and references from over 15,000 peer-reviewed journals from 4,000 publishers worldwide, ensuring broad interdisciplinary coverage. In addition, Scopus not only offers users citation information about the articles covered, but also directly integrates Web and patent searches. Direct links to full-text articles, library resources and other applications like reference management software, make Scopus quicker, easier and more comprehensive to use than any other literature research tool. For more information about Scopus please visit http://www.info.scopus.com.

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet (http://www.thelancet.com) and Cell (http://www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (http://www.sciencedirect.com), Scopus (http://www.scopus.com), Reaxys (http://www.reaxys.com), MD Consult (http://www.mdconsult.com) and Nursing Consult (http://www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (http://www.scival.com) and MEDai's Pinpoint Review (http://www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier ( http://www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (http://www.reedelsevier.com), a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Contact: Jessica Disch, Phone: +1-212-752-8338, E-mail: jdisch@psbpr.com

Contact: Jessica Disch, Phone: +1-212-752-8338, E-mail: jdisch@psbpr.com

Oncology companies on the list are TransMolecular, AngioChem, Ariad, Allos, Gloucester, Oncothyreon, Rexahn, Biothera, Infinity Pharmaceuticals and Cornerstone Pharmaceuticals.

Cardiovascular/metabolic companies are Aryx, XOMA, Array Biopharma, TransTech Pharma, Zafgen, Vitae, Galmed Medical Research, Celladon, Metabolex and Alnylam.

Neuroscience companies are EnVivo Pharmaceuticals Inc., NeurAxon Inc., Allon Therapeutics, Alexza, AFRAXIS, Karo Bio, CeNeRx, Trophos, Prana Biotechnology and Braincells.

Inflammatory/autoimmune companies are Enzo Biochem, Almirall, Orexo, Galactica Pharmaceuticals, Bayhill Therapeutics, Chelsea Therapeutics, LifeCycle Pharma, Lexicon Pharmaceuticals, and Synta Pharmaceuticals.

Companies will present the product's target and first indication(s); other compounds addressing the same target; the relative advantage of the compound; the clinical results to date and general clinical plan for the future; IP on the compound or target; and any partnerships the company currently holds on the compound. Registered attendees have access to pre-conference access to a database that includes detailed technical, non-confidential information on projects available for partnering (pre-clinical and clinical stage).

Industry analysts will open each Top 10 session with therapy area-specific discussions on Matchmaking in Drug Partnering: Identifying the Right Drugs and the Right Partners

A major partnering event

Therapeutic Area Partnerships is the industry's most targeted and efficient partnering meeting for life science companies seeking partnerships in the top therapeutic areas. Decision-makers (business development and R&D) focusing on these therapeutic categories can meet to develop strategic alliances between their companies. Also, attendees enjoy the personal and interactive setting that combines company presentations, 1:1 meetings and networking functions.

Online registration for Therapeutic Area Partnerships is available at www.tapartnerships.com.

Attendees at Therapeutic Area Partnerships will use Windhover's industry-leading partnering software to pre-arrange and schedule partnership meetings. Other opportunities include capitalizing on potential new business and collaboration opportunities with the hottest TA-focused companies; networking with hundreds of potential pharmaceutical and biotech partners through 1:1 meetings, cocktail parties, luncheons and refreshment breaks; hear exciting new statistics, deal case studies and trends in therapeutic area partnering from an unbeatable line-up of senior level speakers; and taking back the most current conference and detailed information on delegates, their companies, projects and technologies.

Top-level executives to lead intriguing content sessions

Leading industry executives will discuss timely issues at Therapeutic Area Partnerships, including Therapeutic Area Partnering: Predicting Pharma Strategies in a Post Primary Care World with Elsevier Business Intelligence's Roger Longman; Who Is your Best Partner?: How Deals Differ in Various Therapeutic Areas; and Deal Structures that Allow Large and Small Companies to Share Risk.

Top industry executives and strategists to speak at Therapeutic Area Partnerships include Jeff Hanke, VP, Cancer Research, AstraZeneca; Peter Wirth, Executive Vice President, Legal and Corporate Development, Genzyme Corp.; and Dr. Jeremy Levin, Senior Vice President, Strategic Transactions, Bristol-Myers Squibb. Additional speakers are listed on the website.

Therapeutic Area Partnerships will also offer several in-depth workshops.

Global Sponsor for Therapeutic Area Partnerships is Campbell Alliance; Gold Industry Sponsors are Astellas, Merck & Co. and Sanofi Aventis; and Association Sponsor is the Licensing Executives Society. Regional Supporting Organization is BioteCanada; Neuroscience Advisor is NI Research; Inflammation Advisor is Healogix; Oncology Advisor is Campbell Alliance; and Cardiovascular/Metabolic Advisor is DefinedHealth. Media Partner is Pharmalicensing.com, and Major Supporting Publications are IN VIVO: The Business & Medicine Report(TM); Start-Up: Emerging Medical Ventures(TM); and "The Pink Sheet."

To register, contact Pat Cardone at (203) 838-4401 ext. 124 or pccardone@windhover.com; or register on the Therapeutic Area Partnerships 2009 website at www.tapartnerships.com.

About Windhover Conferences and Elsevier Business Intelligence

Windhover Conferences is an Elsevier Business Intelligence company, the leading provider of business intelligence and analysis to senior executives in the medical device, pharmaceutical, and biotechnology industries. Publishers of IN VIVO: The Business & Medicine Report, Start-Up: Emerging Medical Ventures, The RPM Report: Regulation Policy Market Access, Medtech Insight, The Pink Sheet and The Pink Sheet Daily, Elsevier and Windhover also host a variety of industry meetings and webinars in both medical device and pharma/biotech, and produce a wide array of market research reports. For more on the companies' products and services, please visit www.ElsevierBI.com.

Contact:
Pat Cardone
(203) 838-4401 ext. 124
Email Contact

SOURCE: Elsevier Business Intelligence

http://www2.marketwire.com/mw/emailprcntct?id=DC0E8C5ACDDEC1D2